Cilostazol in the treatment of schizophrenia
- Conditions
- schizophrenia.schizophrenia
- Registration Number
- IRCT201407151556N61
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 50
1-Diagnosis of Schizophrenia based on DSM- IV criteria; 2- Minimum Score of 60 on Positive and Negative Scale; 3- Age between 18-60; 4-Chronic Schizophrenia- duration of the disorder more than 2 years; 5-Minimum score of 20 in negative sub score.
Exclusion criteria:1-Any other mental disorder on axis I; 2-Any serious medical or neurological problem; 3- IQ less than 70; 4- Substance dependence during the last 6 months(except for nicotine and caffeine); 5-receiving oral antipsychotic medications during the last week or receiving any depot antipsychotic medication during the last month; 6-receiving ECT during the last 14 days ; 7-Hepatic and renal diseases; 8- History of neurosurgery; 9- History of head trauma.
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Severity of schizophrenia. Timepoint: Baseline and weeks 2-4-8 after beginig of treatment. Method of measurement: Positive and Negative Syndrome Scale (PANSS).
- Secondary Outcome Measures
Name Time Method